Vanessa L. Dunleavy, ARNP

Accepting New Patients
Offers Video Visits
1221 Madison Street, Arnold Pavilion, Suite 200
Seattle, WA 98104
2009.3 miles away
Medical Groups & Affiliations
Swedish
Speaks: English
map

Medical Oncology - Swedish Cancer Institute First Hill

1221 Madison Street, Arnold Pavilion, Suite 200, Seattle, WA 98104

Are you covered?

Check to see if your insurance is covered by this provider.

About Vanessa L. Dunleavy

Vanessa Dunleavy is a recipient of the Seattle Top Doctor Award and most recently received the 2023 Seattle Met Award. Vanessa is a board-certified nurse practitioner who spent the majority of her career as a nurse at Memorial Sloan Kettering Cancer Center. She decided it was time to pursue higher education and graduated from Hunter College, New York City, as a nurse practitioner. Vanessa relocated to Seattle, May of 2017, and joined the Swedish oncology department. Her philosophy of care is a holistic approach involving many disciplines.

Medical School

Hunter College, City University of New York
2017

Board Certifications
  • American Academy of Nurse Practitioners, Nurse Practitioner Adult Gerontology Primary Care
Medical Oncology - Swedish Cancer Institute First Hill
1221 Madison Street
Seattle, WA 98104

Medical Groups & Affiliations
Swedish

Vanessa's interests outside work include skiing, reading and exercise.

Clinical Interests

  • Aids Related Malignancies
  • Anaplastic Meningioma
  • Atypical Meningioma
  • Bladder Cancer Genomics
  • Brain Cancer Genomics
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoma Of Unknown Primary
  • Cervical Cancer Genomics
  • Chemoradiation
  • Clear Cell Meningioma
  • Clinical Trials
  • Colon Cancer Genomics
  • Crizotinib
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer Genomics
  • Epithelioid Hemangioendothelioma
  • Epithelioid Malignant Peripheral Nerve Sheath Tumor
  • Erlotinib
  • Fibrous Meningioma
  • Gallbladder Cancer Genomics
  • Gastrointestinal (Gi) Cancer Genomics
  • Genitourinary Cancer Genomics
  • Germinoma
  • Giant Cell Tumor Of The Bone
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Head And Neck Cancer Genomics
  • Histiocytic Sarcoma
  • Immature Teratoma
  • Leukemia Genomics
  • Liver Cancer Genomics
  • Lung Cancer Genomics
  • Lymphedema Therapy
  • Lymphoma Genomics
  • Melanoma Genomics
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Melanotic Schwannoma
  • Meningeal Melanoma
  • Metastatic Liver Cancer
  • Mucosal Melanoma
  • Musculoskeletal Tumor
  • Myeloproliferative Diseases
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Oral Complications Of Cancer
  • Oral Lesions
  • Pancreatic Cancer Genomics
  • Plasma Cell Dyscrasia
  • Prostate Cancer Genomics
  • Pulmonary Metastases
  • Rectal Cancer Genomics
  • Renal Cancer Genomics
  • Retroperitoneal Mass
  • Sarcoma Genomics
  • Side Effects Of Cancer Treatment
  • Skin Cancer Genomics
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer Genomics
  • Supratentorial Primitive Neuroectodermal Tumor
  • Targeted Molecular Therapy
  • Teratoma With Malignant Transformation
  • Thoracic Cancer
  • Thyroid Cancer Genomics
  • Tracheal Cancer
  • Unknown Primary Cancer
  • Vaginal Melanoma